Local genomics giant Illumina Inc. is spinning out a new forensics startup, and (unlike previous spinouts) this upstart will be based in San Diego.
The company is called Verogen Inc., and it was founded by both Illumina and a San Francisco-based venture capital and growth equity firm called Telegraph Hill Partners. Verogen will be providing Illumina’s forensic sequencing technology to criminal casework and other forensic applications.
“The power of genomics to serve the forensic market, while improving justice and public safety, provides a strong case for the need to address remaining barriers to next generation sequencing (NGS) adoption in crime laboratories as quickly as possible,” said THP’s venture partner Paul Grossman. “We believe that Illumina’s market-leading NGS technology and our team of dedicated forensic experts, in combination with the growth capital and resources that THP provides, position Verogen and its customers for long-term success.”
Heading up the new spinout is Kirk Malloy, who will serve as Verogen’s CEO. Malloy has a long history with Illumina, working as an executive with the company for the past 14 years. Most recently, he served as senior vice president and general manager of the life science and applied markets division. That role included oversight of Illumina’s forensics applications.
Verogen, which will be based in Sorrento Valley, currently has 10 employees, Illumina said.